ArticleClinical and experimental pediatrics2026
Red cell distribution width and reticulocyte hemoglobin content as predictors of iron depletion in children with cyanotic congenital heart disease.
Article in Clinical and experimental pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Background: Iron-deficiency anemia is challenging to diagnose in patients with cyanotic congenital heart disease (CCHD) because of the high hemoglobin concentration as a compensatory mechanism for cyanosis. Purpose: This study aimed to identify predictive parameters of iron depletion status and assess the prevalence of iron deficiency in patients with CCHD. Methods: A descriptive study enrolled patients with CCHD aged 6 months to 15 years between September 2022 and September 2023. Participants were categorized into iron depletion and iron sufficiency groups defined by a serum ferritin level <30 ng/mL or transferrin saturation <15%. The clinical characteristics and laboratory parameters were compared between groups. The Youden index was used to determine the optimal cutoff points, maximizing both sensitivity and specificity for the red cell indices. Results: Among the 110 enrolled patients with CCHD, 28 (25.5%) had iron depletion. While hemoglobin (Hb) and hematocrit (Hct) levels were comparable between groups, the iron-depleted group exhibited significantly lower reticulocyte hemoglobin content (CHr) and higher red cell distribution width (RDW). A multivariate analysis identified an RDW ≥18.8% (odds ratio [OR], 7.79; P=0.001) and CHr <28 pg (OR, 4.97; P=0.004) as independent predictors of iron depletion. The diagnostic accuracy improved to 85.4% when these parameters were combined. Conclusion: Iron depletion is highly prevalent in patients with CCHD. Because conventional parameters, such as Hb and Hct, fail to differentiate iron status owing to compensatory mechanisms, CHr and RDW serveas effective predictive tools. This combination offers a practical diagnostic alternative, especially in resource-limited settings, where standard iron studies are unavailable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.